XPH Looks Tempting, but the Five-Year Chart Warns Investors
SPDR S&P Pharmaceuticals ETF has delivered a standout one-year run, yet the longer five-year view casts a shadow. The...
Explore effective ways to make money and pay off debt. Boost your finances and achieve your goals with our actionable tips.
28,655 articlesSPDR S&P Pharmaceuticals ETF has delivered a standout one-year run, yet the longer five-year view casts a shadow. The...
ASML expands beyond its EUV core with a strategic foray into advanced packaging. The move comes as TSMC leads the CoW...
Micron Technology led a Tuesday rally in the memory sector, with peers posting solid gains as a new AMAT collaboratio...
Apollo Global Management posted strong 2025 revenue and raised its dividend, but the stock has fallen as private cred...
Broadcom reports a surge in AI semiconductor revenue and points to a path beyond $100 billion in AI-chip sales by 202...
As IPO risk rises in 2026, Altria’s reliable 6% dividend and decades of payout growth position it as a steadier optio...
On June 3, 2026, stocks take breather wednesday as a rapid rally cools, with the S&P 500 slipping and investors weigh...
A Wall Street note imagines a SpaceX IPO delivering about 40% upside, powered by a diversified revenue mix. This repo...
Oil prices drop to a three-month low following news of a Trump Iran framework, signaling potential relief for inflati...
AI-driven momentum is sweeping through workplaces and markets, yet the official data trail remains far behind. Econom...
A 72-year-old retiree confronts a surprise $19,000 tax bill on his first Required Minimum Distribution, underscoring ...
Russia’s messaging clampdown tests decentralization in the real world, revealing a gap between ideal tech and user wi...